Skip to main content
Latest News
October 19, 2026
Bristol Myers Squibb to Showcase Next-Generation Cancer Modalities and Leadership Across Solid Tumors at ESMO 2026
October 12, 2026
Bristol Myers Squibb Announces Positive Topline Results from the Interim Analysis of Phase 3 ACTION-1 for RYZ101, RayzeBio’s Radiopharmaceutical Therapy, in Patients with GEP-NETs
October 12, 2026
Bristol Myers Squibb Announces Phase 3 ALOFT-IPF Trial Evaluating Admilparant in Adults with Idiopathic Pulmonary Fibrosis Met Primary Endpoint
Latest Events
Event year list
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
October 29, 2026
08:00 AM ET
Bristol Myers Squibb Q3 2026 Results Conference Call
Webcast
(opens in new window)
Preliminary Q3 2026 Acquired IPRD & Licensing Income (PDF)
July 30, 2026
08:15 AM ET
Bristol Myers Squibb Q2 2026 Results Conference Call
Webcast
(opens in new window)
Press Release (PDF)
Quarterly Package of Financial Information (XLS)
Q2 2026 Results Presentation (PDF)
Q2 2026 Results Presentation (with Appendix) (PDF)
Preliminary Q2 2026 Acquired IPRD & Licensing Income (PDF)
June 9, 2026
02:00 PM EST
Goldman Sachs 47th Annual Global Healthcare Conference
Webcast
(opens in new window)